Drug Information

Drug General Information
Drug ID
D0O6KE
Former ID
DIB004205
Drug Name
Repirinast
Synonyms
MY-1250; MY-5116; MY-6116
Drug Type
Small molecular drug
Indication Asthma [ICD10:J45] Approved [551871]
Company
Mitsubishi-Tokyo Pharmaceuticals Inc
Formula
C20H21NO5
Canonical SMILES
c12c(c3c([nH]c1=O)c(c(cc3)C)C)oc(cc2=O)C(=O)OCCC(C)C
PubChem Compound ID
5050
Target and Pathway
Target(s) Histamine receptor Target Info Modulator [526799], [551871]
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 526799Mechanism of action of MY-1250, an active metabolite of Repirinast, in inhibiting histamine release from rat mast cells. Br J Pharmacol. 1992 Mar;105(3):587-90.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.